Hire the Regulatory Medical Writer Who Verifies the Draft, Not the One Who Produces It Fastest

Where Does the Machine-Made Draft Actually Break?

A reviewer flags one sentence in the efficacy narrative of a clinical study report. It says 212 subjects completed the treatment period. Table 14.1.1 says 209. The sentence has the right register, the right hedging, the right cross-reference format, and nobody in the room can say where the number came from, because the paragraph was generated from a prompt holding the protocol, the statistical analysis plan and forty tables at once.

That is the failure mode the seat now exists to prevent. It is not sloppiness and it is not fabrication in the dramatic sense. It is a document that is 97 percent correct and uniformly confident, which is far harder to review than a document that is 80 percent correct and visibly rough. A weak human draft advertises where to look. A generated draft hides its weak points inside good prose, so the reviewer's attention slides across the error rather than catching on it.

The market has started to name this openly. Postings in the field increasingly carry the operating mode in the title or the first requirement line, and they ask for it on top of regulatory writing seniority rather than in place of it. Vendor and CRO commentary on AI-drafted clinical study reports describes the same move, from drafting to drafting-and-verifying. The scale of the surrounding churn is why the seat is contested before it is even defined: 170 million roles created and 92 million displaced by 2030 on the World Economic Forum's projection, with information processing among the drivers ¹, which means every adjacent department is rewriting its job descriptions in the same quarter you are rewriting this one.

Treat the category as still forming. There is no settled title, no dedicated wage series, and no professional consensus yet on what the quality control record for a generated section should look like. That is an argument for hiring someone who will help write the standard rather than waiting for one to arrive, and it sits close to the work of a GxP AI validation specialist, who has the same problem one layer down in the systems themselves.

Which Tells Separate a Verifier From a Fast Drafter?

Give the candidate a generated CSR section with a planted numerical mismatch, the source tables, and thirty minutes. What they do first is the whole interview. The strong ones reconcile numbers against the outputs before reading for style, check that every cross-reference points at a table that exists, and then read the conclusion for a claim the data does not support. The weak ones start editing sentences.

Watch what they want to know before they start. A writer who asks what the draft was generated from, and wants the prompt, the source document list and the model version, is treating it as an output with a provenance; one who accepts it as a manuscript will not be able to explain the error to anybody six months later. Watch, too, how they name what they find. A wrong number, an unsupported inference and a formatting deviation from the ICH E3 structure need different fixes and different escalation, and a candidate who calls all three of them errors will triage badly under submission pressure.

Ask what changes in the QC step when the first draft is machine-made. The honest answer is that sampling stops working and full reconciliation replaces it, at least until the pipeline has a track record, and the candidate who says a fluent draft costs more to review rather than less has understood the whole problem in one sentence. Ask about a health authority question they once answered and what in the original document invited it, because that memory is the strongest available proxy for how carefully somebody writes. Then ask to see the evidence of a check, a QC log or a redlined section, something reconstructable. A verification nobody can reproduce is indistinguishable from no verification when an inspector asks.

One anti-tell. A candidate who offers to detect whether text was machine-written is selling something that does not work, and it is the wrong question anyway. Nothing about the origin of a sentence tells you whether the number in it matches Table 14.1.1. The job is checking claims against sources, whoever or whatever produced them.

Why a Statistical Programmer Outreads a Career Writer Here

Somebody has to decide whether the narrative's 212 or the table's 209 is the authoritative number, and that is a judgment statistical programmers and biostatisticians have been making every working day of their careers. It is the scarcest thing in the room once a pipeline is producing fluent prose at volume, and it is not what a writing background trains. Recruit the obvious feeders, then recruit past them.

The obvious ones are CRO medical writing departments, sponsor-side regulatory writing groups and clinical study report specialists. They already know ICH E3, the module structure of a submission, and what a reviewer at an agency notices. Expect competition there, because those same departments are building AI-assisted operations teams from the inside.

The less obvious feeders are often better. Pharmacovigilance narrative writers have written thousands of short documents under a clock with a legal consequence attached. Clinical data managers know where the data actually disagrees with itself. And outside pharma entirely, aviation and nuclear maintenance technical writers work in a tradition where every statement in a manual has a traceable authority, which transfers faster than a life sciences degree does.

How the good ones got good is worth asking directly. The answers that mean something are specific and unflattering: generating a summary of a study and then discovering the model had smoothed two adverse events into one category; asking for a cross-reference table and finding half the section numbers plausible and nonexistent; building a habit of pasting the source table into the same context and asking the model to state which cell each sentence rests on. What you are listening for is someone who uses these tools constantly and distrusts them constantly, and who can describe a specific check without being prompted to.

Candidates who have never used a generation pipeline misjudge which parts are hard. They assume the prose is the difficulty and the numbers are safe, and it is the other way around. Candidates who trust the output fail more expensively, because a confident wrong sentence inside a submission module is worse than a gap somebody flagged. Interview for the third position, which is fluent use plus routine verification, and treat both extremes as a no.

Source Them Where Submission Documents Already Get Defended

Post where people already sign for regulated documents. The European Medical Writers Association job board is where regulatory writing roles concentrate in Europe, and the American Medical Writers Association, the Regulatory Affairs Professionals Society and Drug Information Association meetings concentrate the same population on the other side of the Atlantic. Those rooms return people who have defended a file. A general job board returns people who have read about AI in medical writing.

Feeder employers follow the evidence. Large CROs staff medical writing at scale and are the most common origin for sponsor-side hires. Mid-size pharmaceutical sponsors with recent filings have writers who have just been through the inspection version of this work. Specialist regulatory writing consultancies rotate people across sponsors quickly, which produces range. And publishing or scientific copy editing teams inside journals produce reference-checking discipline that is difficult to teach.

Search adjacent titles, because the noun has not settled: medical writer AI-assisted operations, regulatory writing lead, submission content manager, scientific content operations specialist, principal medical writer, medical writing automation lead. Set alerts on the duty rather than the title, since the same job is being posted under at least four names right now.

Screen on artifacts before you screen on interviews. Ask for a redacted section a candidate wrote plus the QC record for it, and read both. Writing samples are abundant in this field and unusually honest, and the QC record is the half most candidates have never been asked for. When you write the description, keep the governance language accurate rather than aspirational, the same discipline an AI governance counsel would apply to a policy claim.

How Do You Close One, and Does This Work Sit On-Site?

Close on accountability and tooling before pay. The candidates worth hiring will ask who signs the document, whether they can hold a release when a reconciliation is unfinished, and whether they get access to the pipeline itself or only to its output. A vague answer on the first question loses the offer. A refusal on the last one loses it too, because a writer who cannot see the prompt and the source list cannot be accountable for the result.

On compensation, be honest that the title is too young to have its own benchmark. As of September 2026 no government wage series covers AI-assisted regulatory medical writing, and the postings carrying the operating mode in their title are still few enough to count. The defensible approach is to hire against your existing senior and principal regulatory medical writing bands for the region and sector, then decide deliberately whether the verification accountability justifies a step within that band. For context on the direction of travel, PwC's 2026 AI Jobs Barometer, analyzing close to one billion job advertisements, reports an average wage premium of about 62 percent for roles requiring AI skills ². Treat that as evidence that the premium is real across the economy, not as a multiplier to apply to a medical writing offer.

What kills offers here is predictable: a page or document quota carried over from the pre-pipeline job description, a QC step still staffed for sampling rather than reconciliation, and a review calendar that assumes the machine draft saved time it did not save.

On location, medical writing is one of the most remote-friendly functions in pharmaceutical development, and most postings for this work are remote or hybrid. Three things pull it back on-site. Unblinded data usually lives in a controlled environment with its own access rules. Some sponsors require validated systems reachable only from managed devices or a specific jurisdiction. And submission crunch weeks still run better in a room, because the question of whether the narrative's 212 or the table's 209 is right takes four minutes across a desk and two hours across a ticket queue. Remote with named on-site weeks, written into the offer rather than negotiated in month three, is the arrangement that holds.

See a sample report >